Frederick W Ehret

Title: Innovations of Frederick W. Ehret in Hemostatic Agents

Introduction

Frederick W. Ehret is an accomplished inventor based in Malden, MA (US). He has made significant contributions to the field of medical technology, particularly in the development of hemostatic agents. His innovative work focuses on creating solutions that enhance patient care and improve surgical outcomes.

Latest Patents

Ehret holds a patent for a resorbable hemostatic agent that combines polyethylene glycol and microfibrillar collagen. This invention serves as a delivery component that aids in the application to wound sites. The hemostatic component effectively controls bleeding in solid tissue without delaying or interfering with the healing process. The viscosity of this agent can be adjusted for easy application at various temperatures. This biodegradable and biocompatible hemostatic agent is particularly effective in managing bleeding in bone and other dense tissues.

Career Highlights

Ehret is associated with The Brigham and Women's Hospital, Inc., where he has contributed to advancing medical technologies. His work has been pivotal in developing solutions that address critical challenges in surgical procedures and patient recovery.

Collaborations

Ehret has collaborated with notable professionals in the field, including Dennis Paul Orgill and John Mulliken. These partnerships have fostered innovation and enhanced the effectiveness of his inventions.

Conclusion

Frederick W. Ehret's contributions to the development of hemostatic agents exemplify the impact of innovation in medical technology. His work continues to influence the field and improve patient outcomes.